X0303 4 2009-02-28 0 0001339455 Somaxon Pharmaceuticals, Inc. SOMX 0001024004 HALE DAVID F C/O SOMAXON PHARMACEUTICALS 3721 VALLEY CENTRE DRIVE, SUITE 500 SAN DIEGO CA 92130 1 1 0 0 Executive Chairman Common Stock 2009-02-28 4 A 0 33074 0.00 A 123987 D Common Stock 228107 I By Hale Family Trust UTD 2/10/86 These shares are represented by restricted stock units ("RSUs"). These RSUs will vest upon the first date included within an open trading window under the Company's Insider Trading Policy following the first commercial sale of Silenor(R) in the United States, subject to the director's continued service to the Company on such date. /s/ Matthew Onaitis, Attorney-in-fact 2009-03-03